Research Dosing Guides

Research Dosing Guides

Reconstitution volumes, research dosing ranges, cycle lengths, and timing notes for every compound in the Revial Labs catalogue. Click any product to expand its guide.

Research Use Only. All information on this page relates strictly to laboratory and in vitro research contexts. These compounds are not approved for human or veterinary use. Nothing on this page constitutes medical advice. Always consult appropriate regulatory guidance before handling research peptides.

⚖️

Weight Management & Metabolic

GLP-1 receptor agonists, GHRH analogues, lipolytic peptides

Retatrutide 10mg

GLP-1 / GIP / Glucagon

Triple receptor agonist acting on GLP-1, GIP, and glucagon receptors simultaneously — the most potent of the incretin-class peptides in current research. Studies suggest stronger weight reduction vs dual agonists at equivalent timepoints.

Reconstitution
Add 2ml bac water to 10mg vial = 5mg/ml
1 unit on U100 syringe = 50mcg
Starting Dose
0.5mg once weekly (10 units on U100)
Escalation
Increase by 0.5mg every 4 weeks as tolerated
Target Range
4–8mg weekly (research range)
Administration
SC — abdomen, thigh, or upper arm. Rotate sites.
Reconstituted Storage
2–8°C, use within 28 days

Reconstitution Steps

1Remove cap. Clean stopper with alcohol swab and allow to dry.
2Draw 2ml bacteriostatic water into a 3ml syringe.
3Insert needle and inject water slowly down the inside wall — not directly onto the powder.
4Swirl gently until fully dissolved. Do not shake.
5Refrigerate immediately. Write reconstitution date on label.

Slow titration is critical. GI side effects (nausea, reduced appetite) are dose-dependent and typically resolve after 2–3 weeks at each level. Do not escalate faster than every 4 weeks.

→ View product page

Retatrutide 20mg

GLP-1 / GIP / Glucagon

Triple receptor agonist — same mechanism as the 10mg vial. The 20mg format provides a higher-concentration reconstitution option, reducing injection volume at equivalent doses. Useful in longer research cycles where fewer vial changes are preferred.

Reconstitution
Add 2ml bac water to 20mg vial = 10mg/ml
1 unit on U100 syringe = 100mcg
Starting Dose
0.5mg once weekly (5 units on U100)
Escalation
Increase by 0.5mg every 4 weeks as tolerated
Target Range
4–8mg weekly (research range)
Administration
SC — abdomen, thigh, or upper arm. Rotate sites.
Reconstituted Storage
2–8°C, use within 28 days
Higher concentration = smaller volume per dose. At 10mg/ml, a 0.5mg dose requires only 5 units (0.05ml) on a U100 syringe — less discomfort than the same dose from a 10mg vial. Titration protocol is identical to the 10mg format.

→ View product page

Retatrutide 30mg

GLP-1 / GIP / Glucagon

Triple receptor agonist at the highest single-vial concentration in the Revial catalogue. The 30mg format suits extended research cycles or higher dose ranges — one vial covers 4–7 weeks at typical research doses without frequent reconstitution.

Reconstitution
Add 2ml bac water to 30mg vial = 15mg/ml
1 unit on U100 syringe = 150mcg
Starting Dose
0.5mg once weekly (~3.3 units on U100)
Escalation
Increase by 0.5mg every 4 weeks as tolerated
Target Range
4–8mg weekly (research range)
Administration
SC — abdomen, thigh, or upper arm. Rotate sites.
Reconstituted Storage
2–8°C, use within 28 days
Tip for precision dosing at 15mg/ml: Consider adding 3ml bac water instead of 2ml to get 10mg/ml — identical to the 20mg vial concentration and easier to measure on U100 syringes.

→ View product page

Tirzepatide 20mg

GLP-1 / GIP Dual Agonist

Dual GLP-1 and GIP receptor agonist. One of the most extensively researched dual incretin analogues — modulates glucose homeostasis and appetite signalling simultaneously. Strong phase III clinical trial data backing its metabolic research context.

Reconstitution
Add 2ml bac water to 20mg vial = 10mg/ml
1 unit on U100 = 100mcg
Starting Dose
2.5mg once weekly (25 units)
Escalation
Increase by 2.5mg every 4 weeks
Target Range
5–15mg weekly
Administration
SC — rotate injection sites weekly
Reconstituted Storage
2–8°C, use within 28 days
Consistency: Inject on the same day each week. GI side effects are most pronounced at escalation steps — the 4-week spacing allows the body to adapt before the next increase.

→ View product page

Tirzepatide 30mg

GLP-1 / GIP Dual Agonist

Dual GLP-1 and GIP receptor agonist — same mechanism as the 20mg vial. The 30mg format offers a higher-concentration option for extended research cycles, reducing vial changes at maintenance doses.

Reconstitution
Add 2ml bac water to 30mg vial = 15mg/ml
1 unit on U100 = 150mcg
Starting Dose
2.5mg once weekly (~17 units on U100)
Escalation
Increase by 2.5mg every 4 weeks
Target Range
5–15mg weekly
Administration
SC — rotate injection sites weekly
Reconstituted Storage
2–8°C, use within 28 days
Tip for easier measuring: Add 3ml bac water instead of 2ml to get 10mg/ml — identical concentration to the 20mg vial. At 10mg/ml, 2.5mg = exactly 25 units on a U100 syringe.

→ View product page

Tesamorelin 10mg

GHRH Analogue

Synthetic GHRH analogue that stimulates pituitary GH secretion. One of the few peptides with robust human clinical trial data — FDA-approved (as Egrifta) for HIV-associated lipodystrophy. Strong body composition and visceral fat reduction research profile.

Reconstitution
Add 2ml bac water = 5mg/ml
Research Dose
1–2mg once daily
Timing
Before sleep, fasted (2hr post-meal minimum)
Cycle Length
12–24 weeks
Administration
SC — abdomen preferred
Reconstituted Storage
2–8°C, use within 21 days
Often paired with Ipamorelin (GHRH + GHRP combination) for synergistic GH pulse amplification — a widely used research pairing.

→ View product page

HGH Fragment 176-191 5mg

Lipolytic Fragment

C-terminal fragment of human growth hormone (amino acids 176–191), isolated for its lipolytic activity. Lacks the insulin-sensitising and proliferative effects of full HGH — studied purely in fat metabolism contexts. Fasted administration is essential.

Reconstitution
Add 1ml bac water = 5mg/ml
Research Dose
250–500mcg 1–2x daily
Timing
Fasted — morning on waking and/or 30 min before bed
Cycle Length
8–12 weeks
Administration
SC injection
Reconstituted Storage
2–8°C, use within 21 days
Fasted state is critical. Insulin blunts lipolytic activity. Avoid carbohydrates and fats for at least 30 minutes post-injection.

→ View product page

SLU-PP-332 5mg

ERRα/γ Agonist

Oestrogen-related receptor α/γ (ERRα/γ) agonist. Studied as an exercise mimetic — activates mitochondrial biogenesis pathways associated with endurance adaptation. Preclinical research only; limited human data.

Reconstitution
Add 1ml bac water = 5mg/ml
Preclinical Dose
100–300mcg/kg in animal models
Administration
SC injection (primary route in published studies)
Cycle Length
4–8 weeks (research context)
Reconstituted Storage
2–8°C, use within 21 days
Status
Preclinical only — extrapolate with caution

→ View product page

🔧

Tissue Repair & Recovery

BPC-157, TB-500, and combination blends for connective tissue research

BPC-157 10mg

Gastric Pentadecapeptide

15-amino acid peptide derived from gastric juice protein BPC. One of the most extensively published peptides in preclinical repair research — studied across tendon, ligament, muscle, gut, and neural tissue models.

Reconstitution
Add 2ml bac water = 5mg/ml
1 unit = 50mcg
Systemic Dose
200–500mcg daily — split AM/PM if preferred
Localised Dose
200mcg injected near the target site
Cycle Length
4–12 weeks
Administration
SC or IM — local near injury preferred in repair studies
Reconstituted Storage
2–8°C, use within 28 days

→ View product page

TB-500 10mg

Thymosin β4 Fragment

Synthetic fragment of Thymosin Beta-4. Primarily studied for actin-binding activity and its role in cell migration, angiogenesis, and wound healing. Notably systemic — can reach distant injury sites from a remote injection point.

Reconstitution
Add 2ml bac water = 5mg/ml
Loading Phase
4–8mg weekly for 4–6 weeks
Maintenance Phase
2–4mg every 2 weeks
Administration
SC or IM — does not need to be near the injury site
Cycle Length
4–6 weeks loading, then maintenance as needed
Reconstituted Storage
2–8°C, use within 28 days

→ View product page

Wolverine Blend 20mg

Repair Blend

Pre-blended BPC-157 and TB-500 — the classic tissue-repair pairing. BPC-157 works locally with strong VEGF-related activity; TB-500 provides systemic reach via actin modulation.

Reconstitution
Add 2ml bac water = 10mg/ml total
5mg/ml each component
Research Dose
500mcg–1mg daily
Administration
SC — near injury or abdomen
Cycle Length
4–8 weeks
Composition
BPC-157 10mg / TB-500 10mg (1:1)
Reconstituted Storage
2–8°C, use within 28 days

→ View product page

Skin, Dermal & Pigmentation

GHK-Cu, KPV, MT2, and dermal blend preparations

GHK-Cu 100mg

Copper Tripeptide

Glycyl-L-histidyl-L-lysine copper complex. Among the most studied peptides in skin and collagen biology — fibroblast stimulation, collagen/elastin synthesis, wound remodelling, and hair follicle research. The pale blue colour after reconstitution is the copper chelate and is completely normal.

Reconstitution
Add 10ml bac water = 10mg/ml
Pale blue colour is normal
Systemic Dose
1–2mg daily SC
Topical Concentration
Dilute to 0.1–1mg/ml in saline for topical research
Cycle Length
4–8 weeks
Administration
SC injection or topical solution
Reconstituted Storage
2–8°C, protect from light, use within 28 days

→ View product page

Glow Stack 70mg

Dermal Blend

Dermal and tissue-repair triad. GHK-Cu (50mg) provides the collagen and fibroblast focus; BPC-157 and TB-500 extend the application into wound healing, angiogenesis, and matrix remodelling.

Reconstitution
Add 2.5ml bac water = 28mg/ml total
GHK-Cu 20mg/ml · BPC-157 & TB-500 4mg/ml each · pale blue is normal
Research Dose
10 units daily (0.1ml) = 2mg GHK-Cu + 0.4mg each BPC-157 & TB-500
Administration
SC — abdomen or near area of interest
Cycle Length
4–8 weeks
Composition
GHK-Cu 50mg / BPC-157 10mg / TB-500 10mg
Reconstituted Storage
2–8°C, protect from light, use within 28 days

→ View product page

Klow Blend 80mg

4-Peptide Blend

Glow Stack plus KPV. Adds an anti-inflammatory α-MSH-derived component (NF-κB suppression) to the dermal repair triad.

Reconstitution
Add 2.5ml bac water = 32mg/ml total
GHK-Cu 20mg/ml · others 4mg/ml each · pale blue is normal
Research Dose
10 units daily (0.1ml) = 2mg GHK-Cu + 0.4mg each BPC-157, TB-500 & KPV
Administration
SC injection
Cycle Length
4–8 weeks
Composition
GHK-Cu 50mg / BPC-157 10mg / TB-500 10mg / KPV 10mg
Reconstituted Storage
2–8°C, protect from light, use within 28 days

→ View product page

KPV 10mg

α-MSH Tripeptide

C-terminal tripeptide of α-melanocyte-stimulating hormone. Research focus is NF-κB pathway suppression and anti-inflammatory cytokine modulation. Studied in gut inflammation, skin inflammation, and wound healing contexts.

Reconstitution
Add 2ml bac water = 5mg/ml
SC Dose
500mcg–1mg daily
Oral Dose (GI models)
2–4mg daily (dissolved in water)
Cycle Length
4–8 weeks
Administration
SC injection or oral (route depends on research area)
Reconstituted Storage
2–8°C, use within 28 days

→ View product page

MT2 10mg (Melanotan II)

Melanocortin Agonist

Non-selective melanocortin receptor agonist (MC1R–MC5R). Researched for melanogenesis induction, appetite suppression (MC3R/MC4R), and libido modulation. Requires UV light exposure for tanning response in relevant models.

Reconstitution
Add 2ml bac water = 5mg/ml
1 unit = 50mcg
Loading Dose
0.25–0.5mg daily SC for 1–2 weeks
Maintenance
0.5–1mg 2–3x weekly
Timing
Evening — nausea peaks in first 30 min post-injection
Administration
SC injection
Reconstituted Storage
2–8°C, protect from light, use within 28 days
Start low (0.25mg). Nausea and facial flushing are dose-dependent and most pronounced in early doses. These effects typically subside after the first week.

→ View product page

🧠

Cognitive, Mood & Hormonal

Nootropic peptides, anxiolytics, and hormonal axis modulators

Semax 10mg

ACTH Analogue

Synthetic heptapeptide analogue of ACTH(4-7). Studied in cognitive enhancement, BDNF modulation, neuroprotection, and serotonin/dopamine pathway research. Highly bioavailable via intranasal route.

Reconstitution (nasal)
Add 1ml saline/bac water = 10mg/ml
~1 drop ≈ 50mcg
Intranasal Dose
200–900mcg daily — 2–3 drops per nostril
SC Dose
200–300mcg daily
Cycle Length
2–4 weeks on, 2 weeks off
Administration
Intranasal (preferred) or SC injection
Reconstituted Storage
2–8°C, use within 14 days

→ View product page

Selank 10mg

Anxiolytic Peptide

Synthetic analogue of the immunomodulatory peptide tuftsin. Anxiolytic and nootropic properties — modulates GABAergic activity and BDNF expression. Often researched alongside Semax.

Reconstitution (nasal)
Add 1ml saline/bac water = 10mg/ml
Intranasal Dose
200–300mcg per session — 2–3 drops per nostril
SC Dose
200–300mcg daily
Frequency
1–3x daily depending on protocol
Cycle Length
2–4 weeks
Reconstituted Storage
2–8°C, use within 14 days

→ View product page

Kisspeptin-10 10mg

GnRH Stimulator

10-amino acid fragment of the kisspeptin family. Acts on GPR54 (KISS1R) receptors in the hypothalamus to stimulate GnRH pulses, influencing LH, FSH, and downstream sex hormone release.

Reconstitution
Add 2ml bac water = 5mg/ml
Research Dose
6.4mcg/kg SC (clinical studies)
Or 100–300mcg flat dose
Timing
Before sleep — aligns with natural GnRH pulsatility
Cycle Length
4–8 weeks
Administration
SC injection
Reconstituted Storage
2–8°C, use within 21 days

→ View product page

Longevity & Cellular Health

Mitochondrial peptides, coenzymes, and growth hormone secretagogues

Ipamorelin 10mg

Selective GHRP

Highly selective growth hormone releasing peptide. Stimulates pituitary GH secretion with minimal cortisol or prolactin elevation. Researched in body composition, recovery, and sleep quality models.

Reconstitution
Add 2ml bac water = 5mg/ml
1 unit = 50mcg
Research Dose
200–300mcg per injection
Frequency
1–3x daily — most critical dose is pre-sleep
Timing
Fasted (2+ hrs post-meal). Before sleep and/or pre-training.
Cycle Length
8–12 weeks
Reconstituted Storage
2–8°C, use within 21 days
Classic pairing: Ipamorelin + Tesamorelin (GHRP + GHRH) produces synergistic GH pulse amplification.

→ View product page

NAD+ 500mg

Coenzyme / Sirtuin Activator

Nicotinamide adenine dinucleotide — essential coenzyme in cellular metabolism. Research centres on SIRT1/SIRT3 sirtuin activation, mitochondrial function, DNA repair, and age-associated NAD+ decline.

Reconstitution
Add 5ml sterile/bac water = 100mg/ml
Research Dose
250–500mg per session
Frequency
Daily for loading week; 1–2x weekly maintenance
Administration
SC injection — slow push. IV requires medical oversight.
Cycle Length
Ongoing — weekly maintenance
Reconstituted Storage
2–8°C, protect from light, use within 14 days

→ View product page

MOTS-C 10mg

Mitochondrial Peptide

Mitochondrial open reading frame of the 12S rRNA type-C. Activates AMPK and FOXO pathways. Research interest in insulin sensitivity, metabolic flexibility, and exercise mimicry. Endogenous levels decline with age.

Reconstitution
Add 2ml bac water = 5mg/ml
Research Dose
5–10mg weekly SC
Timing
Morning — aligns with circadian AMPK activation patterns
Cycle Length
4–8 weeks
Administration
SC injection
Reconstituted Storage
2–8°C, use within 21 days

→ View product page

Universal Reconstitution & Storage Rules

Never Shake

Swirl gently or roll between palms. Shaking denatures peptide bonds and reduces potency.

Water to Powder, Not Powder to Water

Always inject bac water slowly down the inside wall of the vial — never directly onto the lyophilised cake.

Label Everything

Write the reconstitution date on every vial. Most peptides are stable for 21–28 days refrigerated.

No Freeze-Thaw Cycles

Once reconstituted, do not refreeze. Freeze-thaw cycles cause irreversible peptide degradation.

Use Insulin Syringes

U100 1ml insulin syringes allow precise low-volume dosing. 1 unit = 0.01ml — ideal for mcg-range doses.

Use the Peptide Calculator

Our Peptide Calculator converts vial content + water volume into per-unit doses automatically.